The clinical and pharmacological MAO-Is increased the neurotransmitters in the nervous system, reduced H2O2 and oxidative stress, and provided neuroprotection [49], without which depression patients on other treatments would have MAO-A toxic activity that would remain aggravated [50]. Here, MAOA is linked to depressive symptom measurement.